19:15 Now on air My India

Watch online
My India



My India

“My India” program tells the story of the origins of the Indian society traditions and shows how the...

Watch online

19:40 Next online BRICSINFORM





We are making reports on the most important events from the scene, from exhibitions and premieres, f...

15 September 2021 15:34

Regulator approves Covid-19 pill study in South Africa

Regulator approves Covid-19 pill study in South Africa

The South African Health Products Regulatory Authority has approved the study of an orally administered pill for patients with symptomatic Covid-19 who do not require hospital care.  Business Tech reports. 

The study is already ongoing in the US, with the expansion of study sites underway to further accelerate recruitment, said Nasdaq-listed RedHill Biopharma, a speciality biopharmaceutical company that is conducting the trial.

The trial is aimed at evaluating treatment in patients with symptomatic Covid-19 early in the course of the disease, with a simple once-daily oral treatment that can be prescribed and used in the largest non-hospitalised patient population, the group said.

“South Africa continues to face an onslaught of Covid-19 that is claiming many lives and causing significant distress to the healthcare system,” said Terry Plasse, medical director at RedHill.

“South Africa, along with the US and rest of the world, urgently need the ability to easily and effectively treat Covid-19 and its variants, both inside and outside the hospital setting. It is important to be able to treat patients early in the course of the disease to prevent progression to more severe symptoms.”

This week South Africa also approved Pfizer’s vaccine for use for children over the age of 12, a boost to the country’s immunisation program.

The move follows a review of updated safety and efficacy information and doesn’t translate into a procurement decision, the South African Health Products Regulatory Authority said Sunday (12 September).

Regulators approved the vaccine developed by Pfizer and BioNTech for local use in adults in March.

Africa’s most developed country has been the hardest hit by the pandemic, reporting the highest number of infections. Around 12% of the nation has been fully vaccinated, with the country of about 60 million people now bracing for a fourth wave of infections to hit in early December.

The approval comes after Sinovac Biotech said a Covid-19 vaccine trial in infants, children and adolescents would take place in South Africa as part of a global study.


More on the subject
24 September 15:28
South Africa to build new mega-bridge by 2026
24 September 13:01
Intl' cultural expo, tourism festival on Silk Road open in NW China
24 September 11:18
Delhi reports 24 new COVID cases in last 24 hours
23 September 18:01
SAA returns to the skies on Thursday
23 September 16:48
In Brazil the Internet will be made more accessible
23 September 15:33
Russian stores will have a separate place for organic foods